Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 13Prostatic Neoplasms 11Kidney Neoplasms 6Parkinson Disease 4, Autosomal Dominant Lewy Body 3Wilms Tumor 2Carcinoma, Renal Cell 2Urologic Neoplasms 1Urethral Neoplasms 1Testicular Neoplasms 1Teratoma 1Renal Pelvis and Ureter Urothelial Carcinoma 1Prostate CA 1Prostate Adenocarcinoma 1Pain, Postoperative 1Pain 1Ovarian Germ Cell Cancer 1Oligometastatic Renal Cell Carcinoma 1Neoplasms, Second Primary 1Neoplasms 1Neoplasm Metastasis 1Muscle Invasive Bladder Cancer 1Lung Neoplasms 1Endodermal Sinus Tumor 1Directly Observed Therapy 1Carcinoma, Transitional Cell 1Adenocarcinoma 1Acute Kidney Injury 1

Interventions

tislelizumab 2Cystectomy 2vistusertib 1toripalimab 1olaparib 1liposomal doxorubicin 1durvalumab 1disitamab vedotin 1danvatirsen 1adavosertib 1Surgical Procedures, Operative 1Rutin 1Radiation 1RC48 antibody 1Neoadjuvant Therapy 1Gemcitabine 1Cisplatin 1Chemoradiotherapy 1AZD4547 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Muscle Invasive Bladder Cancer × Surgical Procedures, Operative × Genitourinary × Clear all
NCT02716896 2019-11-25

Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer

The University of Texas Health Science Center at San Antonio

Phase NA Terminated
2 enrolled 8 charts
Genitourinary

Muscle Invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡